...a top donor.
A company controlled by a longtime political donor gets a no-bid contract to supply an experimental remedy for a threat that may not exist.
Reporting from Washington—
Over the last year, the Obama administration has aggressively pushed a $433-million plan to buy an experimental smallpox drug, despite uncertainty over whether it is needed or will work.
Senior officials have taken unusual steps to secure the contract for New York-based Siga Technologies Inc., whose controlling shareholder is billionaire Ronald O. Perelman, one of the world's richest men and a longtime Democratic Party donor.
more status quo politics here:
$443 million for a smallpox drug some experts say we don't need - latimes.com
A company controlled by a longtime political donor gets a no-bid contract to supply an experimental remedy for a threat that may not exist.
Reporting from Washington—
Over the last year, the Obama administration has aggressively pushed a $433-million plan to buy an experimental smallpox drug, despite uncertainty over whether it is needed or will work.
Senior officials have taken unusual steps to secure the contract for New York-based Siga Technologies Inc., whose controlling shareholder is billionaire Ronald O. Perelman, one of the world's richest men and a longtime Democratic Party donor.
more status quo politics here:
$443 million for a smallpox drug some experts say we don't need - latimes.com